Clinical Study of Previously Untreated Patients With Malignant Melanoma
NCT00232726
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Melanoma
Neoplasm Metastasis
Interventions
DRUG:
CP-4055 (ELACYT)
Sponsor
Clavis Pharma